Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

Por Patrick Arnaud-Coffin, Mehdi Brahmi, Hélène Vanacker, Lauriane Eberst, Olivier Tredan, Valery Attignon, Daniel Pissaloux, Emilie Sohier, Philippe Cassier, Gwenaelle Garin, David Pérol, Jean-Yves Blay, Armelle Dufresne
Publicado em 2020-12-01